Cargando…
The second and third amino acids of Pam2 lipopeptides are key for the proliferation of cytotoxic T cells
The TLR2 agonist, dipalmitoyl lipopeptide (Pam2LP), has been used as an immune adjuvant without much success. Pam2LP is recognised by TLR2/6 receptors in humans and in mice. This study examined the proliferative activity of cytotoxic T lymphocytes (CTL) using mouse Ag-presenting dendritic cells (DCs...
Autores principales: | Takeda, Yohei, Azuma, Masahiro, Hatsugai, Ryoko, Fujimoto, Yukari, Hashimoto, Masahito, Fukase, Koichi, Matsumoto, Misako, Seya, Tsukasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830919/ https://www.ncbi.nlm.nih.gov/pubmed/29848176 http://dx.doi.org/10.1177/1753425918777598 |
Ejemplares similares
-
The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation
por: Azuma, Masahiro, et al.
Publicado: (2010) -
Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide
por: Takeda, Yohei, et al.
Publicado: (2018) -
TLR2-Dependent Induction of IL-10 and Foxp3(+)CD25(+)CD4(+) Regulatory T Cells Prevents Effective Anti-Tumor Immunity Induced by Pam2 Lipopeptides In Vivo
por: Yamazaki, Sayuri, et al.
Publicado: (2011) -
Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8(+) T cells during vaccine immunotherapy
por: Takeda, Yohei, et al.
Publicado: (2016) -
Adjuvant immunotherapy for cancer: both dendritic cell-priming and check-point inhibitor blockade are required for immunotherapy
por: SEYA, Tsukasa, et al.
Publicado: (2018)